Where is Artelo Biosciences Inc (NASDAQ: ARTL) Heading?
Artelo Biosciences Inc (NASDAQ: ARTL), the clinical-stage biopharmaceutical company, had recently reported its financial results for the Q2-2021 for the duration ending on February 28, 2021. The company’s net income is reported at 36.19%, down from a year before $1.87 million. The company’s cash on hand increased 440.03% on a year-over-year basis at $10.71 million. The headquarters of the company is in California, United States. There has been a 338.32%…